PGRMC1 and lung adenocarcinoma: PGRMC1/Sigma-2 receptor is confirmed to play key roles in the function of tumor proliferation (such as breast tumors, lung adenocarcinoma cells, and ovarian cancer) and chemoresistance (44–47).